How obstetrics and gynecology show up on the MCCQE
The MCCQE checks whether you can safely care for patients at the start of supervised practice. In obstetrics and gynecology that means recognizing emergencies early, ordering the test that changes management, starting first-line treatment, and knowing when a patient needs an obstetrician or gynecologist now rather than later. You will not be asked to perform a cesarean section or a hysterectomy. You will be asked who needs one and how fast.
OB/GYN content is spread through the MCC Examination Objectives. Vaginal bleeding, amenorrhea, pelvic pain, infertility, contraception, prenatal care, labour, postpartum care, breast lumps and sexual assault are all objectives, and many medical objectives (hypertension, diabetes, thyroid disease, depression) are also tested in a pregnant patient. A question about chest pain can become an obstetric question the moment the stem says the patient is 30 weeks pregnant.
The blueprint applies here as everywhere. Acute care items cover ectopic pregnancy, eclampsia and hemorrhage. Chronic care items cover endometriosis, menopause and polycystic ovary syndrome. Health promotion and illness prevention items cover folic acid, prenatal screening, vaccines in pregnancy and cervical screening. Psychosocial items cover postpartum depression, intimate partner violence and unplanned pregnancy. The physician activities are all present: diagnosis, management, communication (counselling about options) and professional behaviour (consent, confidentiality with adolescents, respect for autonomy). The MCC does not publish item counts by discipline, so prepare OB/GYN as a core area rather than guessing a number.
- Judgment over technique: urgency, first test, first treatment, when to refer
- Medical conditions are retested in pregnancy with different drug choices
- Counselling, consent and confidentiality are part of the content, not extras
The four habits that solve most OB/GYN questions
First, establish pregnancy status. Any person of reproductive age with bleeding, pain, amenorrhea or a new medication decision needs a pregnancy test before anything else. Many distractors are reasonable steps that become wrong because the stem never confirmed pregnancy status. When the stem gives a positive test with pain or bleeding, your next thought is location: an intrauterine pregnancy on transvaginal ultrasound, or a possible ectopic.
Second, check stability. A pregnant patient compensates well and then decompensates fast. Tachycardia, a low blood pressure, shoulder-tip pain or a falling hemoglobin changes the answer from investigation to resuscitation and urgent surgery. In the third trimester, lateral positioning to relieve aortocaval compression is part of resuscitation.
Third, think about two patients. In obstetrics the fetus matters, but the mother is treated first. Stabilizing the pregnant patient is the best way to protect the fetus. When a stem asks about fetal assessment in an unstable mother, the correct answer is usually maternal resuscitation.
Fourth, apply the gestational age. The same symptom means different things at 8, 24 and 38 weeks, and the right action changes with it. Antenatal corticosteroids, magnesium sulfate for fetal neuroprotection, tocolysis and timing of delivery all depend on the gestation in the stem. Write the gestational age down before you read the options.
- Pregnancy test first, then location of the pregnancy
- Stable or unstable decides the branch
- Treat the mother to protect the fetus
- Gestational age changes the correct answer
Pain or bleeding in early pregnancy: the decision path
- 1Confirm pregnancyUrine or serum hCG in every person of reproductive age with pain or bleeding. No test, no next step.
- 2Check stabilityTachycardia, hypotension, peritonism or shoulder-tip pain mean resuscitation and urgent gynecology review.
- 3Locate the pregnancyTransvaginal ultrasound with a quantitative hCG. Intrauterine, ectopic or pregnancy of unknown location.
- 4Check Rh statusRh-negative unsensitized patients with bleeding or a sensitizing event need Rh immune globulin.
- 5Manage and follow upExpectant, medical or surgical care based on the diagnosis, stability and her wishes, with clear return precautions.
High-yield obstetric decision points
Prenatal care questions test routine screening and prevention: folic acid before conception, offering aneuploidy screening to every pregnant patient, blood group and antibody screen, infectious disease screening, gestational diabetes screening in the second trimester, group B streptococcus screening late in the third trimester, and influenza, pertussis and COVID-19 vaccination during pregnancy as recommended by NACI. Live vaccines such as MMR and varicella are deferred until after delivery.
Hypertensive disorders are a favourite. Know the thresholds for hypertension and severe hypertension, the features that make preeclampsia severe (headache, visual change, epigastric pain, low platelets, rising liver enzymes or creatinine), the oral first-line drugs (labetalol, nifedipine, methyldopa) and the urgent treatment of severe hypertension. Magnesium sulfate prevents and treats eclamptic seizures. Delivery is the definitive treatment, and the question is usually about timing. Low-dose ASA started early in pregnancy for patients at high risk of preeclampsia is a classic prevention item.
Bleeding questions depend on the trimester. Early bleeding means miscarriage or ectopic pregnancy. Late bleeding means placenta previa (painless) or abruption (painful, tender uterus), and you never perform a digital vaginal examination until ultrasound has excluded a previa. Postpartum hemorrhage is managed with the four Ts (tone, trauma, tissue, thrombin) and a stepwise sequence of uterine massage and uterotonics. Every Rh-negative unsensitized patient with bleeding or a sensitizing event needs Rh immune globulin.
The postpartum period is tested more than candidates expect: postpartum depression and psychosis, breastfeeding support, contraception after delivery, and follow-up of conditions that started in pregnancy, such as glucose testing after gestational diabetes and long-term cardiovascular risk after preeclampsia.
Red flags that change the OB/GYN answer
High-yield gynecology decision points
Abnormal uterine bleeding is the core gynecology presentation. The approach is pregnancy test, hemodynamic status, a structured cause (the PALM-COEIN system), complete blood count and ferritin, and endometrial sampling when age or risk factors raise concern for hyperplasia or cancer. Postmenopausal bleeding is cancer until proven otherwise and needs endometrial assessment.
Contraception questions test medical eligibility more than brand names. Estrogen is avoided in migraine with aura, smokers aged 35 and older, recent venous thromboembolism, and the early postpartum weeks. Long-acting reversible methods are the most effective. For emergency contraception, the copper IUD is the most effective option, ulipristal is next, and levonorgestrel is least effective, especially as body weight rises.
Amenorrhea, polycystic ovary syndrome, infertility and menopause are reasoning topics: rule out pregnancy, check TSH and prolactin, then follow the work-up. Pelvic pain questions mix emergencies (ectopic, torsion, pelvic inflammatory disease) with chronic conditions such as endometriosis, where empiric hormonal treatment is reasonable before laparoscopy. Screening questions ask you to follow Canadian programs for cervical and breast cancer, and to avoid screening tests that are not recommended, such as CA-125 or pelvic ultrasound for ovarian cancer in average-risk patients.
Canadian practice points that change the answer
Several OB/GYN answers differ between Canadian and US resources, and a US-trained instinct can cost marks. Cervical screening in most Canadian provinces starts later than the US starting age, and many provinces now use HPV-based primary screening. The MCCQE expects you to follow the provincial program logic: no routine screening of young adolescents, defined intervals, and stopping at an upper age after adequate negative results.
Gestational diabetes screening in Canada follows Diabetes Canada, whose preferred approach is a 50 g glucose challenge followed, when abnormal, by a 75 g oral glucose tolerance test, with Canadian SI thresholds in mmol/L. Insulin remains the standard first pharmacologic choice when diet and activity do not reach targets.
Some drugs differ. Ergonovine is the ergot uterotonic named in Canadian protocols, and carbetocin is widely used in Canada for cesarean births. Mifepristone with misoprostol is available in Canada by prescription and can be dispensed by community pharmacists. Abortion is not regulated by the Criminal Code in Canada, and access is a health-system question rather than a criminal law question. Levonorgestrel emergency contraception is available without a prescription.
Consent and confidentiality follow Canadian law. A mature minor can consent to contraception, STI care and pregnancy care without a parent if they understand the treatment and its consequences. Adult sexual assault is not reportable to police without the patient's consent, but suspected child abuse must be reported to child protection services. CMPA guidance and provincial college policies are the references.
- Provincial cervical screening programs, not US start ages
- Diabetes Canada two-step GDM screen with mmol/L thresholds
- Mature minor consent for sexual and reproductive care
- Medication abortion by prescription, dispensed in community pharmacies
Canadian OB/GYN answers versus common US habits
Canadian practice (expected on the MCCQE)
- Cervical screening start age set by provincial programs, many moving to HPV-based testing
- Diabetes Canada preferred GDM screen: 50 g challenge, then 75 g OGTT if abnormal
- Ergonovine named as the ergot uterotonic
- Mature minor consent based on capacity, not a fixed age
- Medication abortion prescribed and dispensed through community pharmacies
Common US or other-system habit
- Screening from age 21 as a fixed national start
- Two-step screen using a 100 g three-hour tolerance test
- Methylergonovine named as the ergot uterotonic
- Minor consent rules defined by state statutes
- Access shaped by state laws and dispensing restrictions
How to read OB/GYN stems
Underline the gestational age, the parity and the vital signs. Then look for the words that decide the branch: painless versus painful bleeding, a tender versus soft uterus, ruptured versus intact membranes, regular contractions with cervical change versus contractions without change. In gynecology, note the age, menstrual history, sexual history and whether the patient wants pregnancy now, later or never, because that preference often decides the treatment.
Lead-ins tell you what the examiners want. 'Most appropriate next step' usually means the safest step that moves care forward, often an investigation or stabilization rather than definitive surgery. 'Most appropriate management' asks for the treatment itself. 'What would you tell her' is a communication item: the correct option is accurate, non-judgmental and respects her choices. When two options are both correct in principle, choose the one that fits the gestational age and the patient's stated goals.
How to prepare OB/GYN for the MCCQE
Start with obstetrics because it carries the most emergencies and the most guideline-specific numbers. Learn the trimester-based approach to bleeding, the hypertension and preeclampsia rules, the gestational diabetes screen and the postpartum hemorrhage sequence until you can write them from memory. Then move to gynecology: abnormal bleeding, contraception eligibility, amenorrhea, screening, pelvic pain and menopause. Finish with high-risk pregnancy and adolescent gynecology, which tie the two together.
Read the SOGC guidelines for the topics you miss in practice questions, not cover to cover. After each block of questions, write down the decision point you got wrong in one line. Those lines become your final review list. In the last two weeks, mix OB/GYN questions with medicine and psychiatry so you practise recognizing a pregnancy hidden inside a non-obstetric stem.
How the MCCQE frames OB/GYN: three mini cases
OB/GYN items reward the candidate who sorts the patient into the right branch before choosing an action. The three short cases below show how a stem is built and where the marks sit.
Case one. A 27-year-old woman has lower abdominal pain and light spotting. Her last period was seven weeks ago and her urine pregnancy test is positive. Heart rate and blood pressure are normal, and she has mild unilateral tenderness. The first branch is stability, and she is stable. The next step is a quantitative hCG and a transvaginal ultrasound to locate the pregnancy. Sending her home with reassurance, or booking a routine dating scan in a few weeks, is the trap. If ultrasound shows no intrauterine pregnancy with a raised hCG, ectopic pregnancy is managed medically or surgically depending on her stability, the hCG level, the ultrasound findings and her ability to attend follow-up.
Case two. Twenty minutes after a vaginal birth, a 33-year-old has heavy bleeding. Oxytocin was given with delivery of the shoulder. Her uterus is soft and above the umbilicus. Tone is the most common cause, so the next step is bimanual uterine massage, more uterotonics and calling for help, while two large-bore IV lines, fluids and blood products are arranged. Options that jump straight to hysterectomy, or that order an ultrasound before treating an obviously atonic uterus, are wrong because they delay effective care.
Case three. A 15-year-old asks for contraception and does not want her parents told. She understands how the methods work and their risks. In Canada, a capable minor can consent to her own care, so the correct answer is to counsel her on options, including long-acting reversible methods and condoms for STI prevention, offer STI testing, keep her information confidential and screen for coercion or abuse. Refusing until a parent attends is the wrong answer.
- Ectopic suspicion: stability, quantitative hCG, transvaginal ultrasound
- Postpartum hemorrhage: treat tone first while resuscitating
- Adolescent contraception: capacity decides consent, confidentiality protects access
Interpreting tests in pregnancy and gynecology
Normal values shift in pregnancy, and stems use this to set traps. Hemoglobin falls because plasma volume rises more than red cell mass. Creatinine falls because glomerular filtration rises, so a creatinine that would be normal in a non-pregnant adult can be abnormal in late pregnancy. Alkaline phosphatase rises because the placenta produces it, so a raised value alone does not mean liver disease. Thyroid tests must be read against pregnancy-specific ranges. When a stem gives you a value without a reference range, think about which direction pregnancy moves it.
Quantitative hCG is useful for its trend and for comparison with ultrasound findings, not as a single number that diagnoses. Ultrasound answers the key early questions: is the pregnancy intrauterine, is there cardiac activity, how many fetuses, and how far along is it. In later pregnancy it locates the placenta before any digital examination in a patient who is bleeding.
Fetal heart rate tracings in Canada are described with the SOGC classification of normal, atypical and abnormal. An abnormal tracing calls for intrauterine resuscitation measures, such as changing the maternal position, giving IV fluids, stopping oxytocin and correcting maternal hypotension, while you assess for the cause and plan delivery if the pattern does not improve.
In gynecology, the tests most often asked about are the pregnancy test, CBC and ferritin, TSH and prolactin in amenorrhea, endometrial biopsy in abnormal bleeding with risk factors, pelvic ultrasound for a mass or structural cause, and nucleic acid amplification testing for chlamydia and gonorrhea. CA-125 is not a screening test for average-risk patients.
- Pregnancy lowers hemoglobin and creatinine and raises alkaline phosphatase
- hCG: follow the trend and match it with the ultrasound
- SOGC tracing categories: normal, atypical, abnormal
- CA-125 is not for screening average-risk patients
Medications in pregnancy and breastfeeding
Many questions turn on whether a drug is safe in pregnancy. The exam tends to use well-known examples. ACE inhibitors and ARBs are avoided in pregnancy, so a patient with chronic hypertension planning pregnancy is switched to labetalol, nifedipine or methyldopa. Warfarin is avoided in most pregnancies, and low molecular weight heparin is used for venous thromboembolism. Valproate carries a high risk of birth defects and developmental harm, so it is avoided in people who could become pregnant when alternatives exist. Isotretinoin requires reliable contraception. Statins are usually stopped. Methotrexate is a teratogen and is also used to treat ectopic pregnancy.
Safe choices also appear as answers. Acetaminophen is the usual first choice for pain and fever. Insulin is the standard for diabetes in pregnancy when lifestyle measures are not enough. Inactivated influenza vaccine and acellular pertussis vaccine are recommended during pregnancy. Most common drugs are compatible with breastfeeding, and the exam favours supporting breastfeeding rather than stopping it when a safe alternative exists.
Preconception care brings these points together: review every medication, start folic acid, update vaccines such as MMR and varicella before conception, and optimize chronic conditions such as diabetes, hypertension, epilepsy and thyroid disease.
- Avoid in pregnancy: ACE inhibitors, ARBs, warfarin, valproate, isotretinoin, statins, methotrexate
- Use instead: labetalol or nifedipine, LMWH, insulin, acetaminophen
- Breastfeeding is usually compatible with treatment
OB/GYN in NAC stations
OB/GYN topics are common NAC material because they test history-taking and counselling well. Expect stations such as a first prenatal visit, contraception counselling, abnormal bleeding history, a positive pregnancy test with pain, postpartum low mood, or screening for intimate partner violence. In each, the marks come from a structured history (menstrual, obstetric, sexual and medication history), asking about safety, and a clear, non-judgmental plan that respects the patient's choices.
Practise saying the sensitive questions out loud until they feel natural. Asking about sexual partners, pregnancy intentions, mood and safety at home in a calm, routine way is a skill, and candidates who rush or avoid these questions lose easy marks.
| Presentation | Key clue in the stem | Expected first move |
|---|---|---|
| Pain or bleeding in early pregnancy | Positive hCG, no intrauterine pregnancy on ultrasound | Assess stability, then evaluate for ectopic pregnancy |
| Bleeding after 20 weeks | Painless, bright red, soft uterus | Ultrasound for previa before any digital exam |
| Bleeding after 20 weeks | Painful, tender firm uterus, fetal distress | Resuscitate and plan delivery for abruption |
| Severe hypertension in pregnancy | BP in the severe range with headache or low platelets | Urgent antihypertensive, magnesium sulfate, plan delivery |
| Heavy bleeding after birth | Soft boggy uterus despite oxytocin | Uterine massage and second-line uterotonics |
| Abnormal uterine bleeding | Age 40 or older or risk factors for hyperplasia | Endometrial biopsy after a pregnancy test |
| Postmenopausal bleeding | Any bleeding a year after the last period | Endometrial assessment for cancer |
| Emergency contraception request | Higher body weight or intercourse several days ago | Offer the copper IUD as most effective |
| Low mood after delivery | Weeks after birth, persistent symptoms, impaired function | Screen for depression and ask about safety |
Worked examples
Choose an answer to see the reasoning for every option.
Example 1
A 31-year-old G1P0 at 35 weeks' gestation presents to the obstetric triage unit with a severe frontal headache and spots in her vision. Blood pressure is 166/112 mm Hg on two readings 15 minutes apart. Urine protein-to-creatinine ratio is elevated. Platelets are 92 x 10^9/L, ALT 110 U/L, creatinine 78 micromol/L. The fetal heart rate tracing is normal.
What is the most appropriate next step?
-
This is preeclampsia with severe features. Outpatient oral therapy is unsafe because the risk of stroke, eclampsia and abruption is immediate.
-
Severe hypertension needs urgent treatment (IV labetalol, oral nifedipine or IV hydralazine). Magnesium sulfate prevents eclampsia, and delivery after stabilization is the definitive treatment at 35 weeks.
-
Expectant management to 37 weeks is for preeclampsia without severe features. With headache, visual symptoms, low platelets and raised liver enzymes, delivery is indicated after stabilization.
-
Delivery is needed, but the mother must be stabilized first. Operating with uncontrolled severe hypertension risks maternal stroke, and the mode of delivery is not automatically cesarean.
-
Bed rest does not treat preeclampsia, and delaying antihypertensive and magnesium therapy exposes her to seizures and stroke.
Show answer and reasoning
Answer: B. IV labetalol, magnesium sulfate, then deliver
- A. This is preeclampsia with severe features. Outpatient oral therapy is unsafe because the risk of stroke, eclampsia and abruption is immediate.
- B. Severe hypertension needs urgent treatment (IV labetalol, oral nifedipine or IV hydralazine). Magnesium sulfate prevents eclampsia, and delivery after stabilization is the definitive treatment at 35 weeks.
- C. Expectant management to 37 weeks is for preeclampsia without severe features. With headache, visual symptoms, low platelets and raised liver enzymes, delivery is indicated after stabilization.
- D. Delivery is needed, but the mother must be stabilized first. Operating with uncontrolled severe hypertension risks maternal stroke, and the mode of delivery is not automatically cesarean.
- E. Bed rest does not treat preeclampsia, and delaying antihypertensive and magnesium therapy exposes her to seizures and stroke.
Preeclampsia with severe features: control blood pressure, give magnesium sulfate, stabilize, then deliver.
Based on: SOGC guideline on hypertensive disorders of pregnancy
Example 2
A 24-year-old woman attends a walk-in clinic asking for emergency contraception. She had unprotected vaginal intercourse 4 days ago. Her last menstrual period began 16 days ago and her cycles are regular. She has no medical conditions and takes no medications. Her weight is 96 kg and BMI 35 kg/m2. Urine pregnancy test is negative.
Which option is most effective for her?
-
Levonorgestrel is least effective late in the window and with higher body weight. It is a reasonable fallback but not the most effective choice.
-
The combined pill (Yuzpe) method is less effective than all the other options and causes more nausea.
-
A doubled levonorgestrel dose is sometimes suggested for higher weight, but it is still less effective than the copper IUD and is not well supported at day 4.
-
The copper IUD is the most effective emergency contraceptive, works up to 7 days after intercourse, is not affected by body weight and provides ongoing contraception.
-
Ulipristal is more effective than levonorgestrel up to 5 days and is a good oral choice, but its effectiveness also falls with higher weight and it remains less effective than the copper IUD.
Show answer and reasoning
Answer: D. Copper IUD inserted at this visit today
- A. Levonorgestrel is least effective late in the window and with higher body weight. It is a reasonable fallback but not the most effective choice.
- B. The combined pill (Yuzpe) method is less effective than all the other options and causes more nausea.
- C. A doubled levonorgestrel dose is sometimes suggested for higher weight, but it is still less effective than the copper IUD and is not well supported at day 4.
- D. The copper IUD is the most effective emergency contraceptive, works up to 7 days after intercourse, is not affected by body weight and provides ongoing contraception.
- E. Ulipristal is more effective than levonorgestrel up to 5 days and is a good oral choice, but its effectiveness also falls with higher weight and it remains less effective than the copper IUD.
For emergency contraception, the copper IUD is the most effective option and is not affected by weight or late timing within 7 days.
Based on: SOGC Canadian Contraception Consensus (emergency contraception)
Example 3
A 26-year-old G2P1 at 28 weeks' gestation attends a routine prenatal visit. Her pregnancy has been uncomplicated, with no bleeding, trauma or abdominal pain. Her blood group is O Rh negative and her antibody screen at the first visit was negative. The father's blood group is unknown. Blood pressure 112/70 mm Hg, fundal height 28 cm.
What is the most appropriate next step?
-
Repeat antibody testing has a role, but on its own it does not prevent sensitization. Routine prophylaxis at 28 weeks is the key step.
-
Paternal testing is not required before routine antenatal prophylaxis, and an unknown or uncertain father is common. Prophylaxis should not be delayed.
-
A Kleihauer-Betke or similar test measures fetomaternal hemorrhage after a sensitizing event or delivery. It is not needed for routine prophylaxis without an event.
-
A postpartum dose is given if the baby is Rh positive, but waiting until delivery misses the routine antenatal dose that prevents most late-pregnancy sensitization.
-
An Rh-negative, unsensitized patient should receive Rh immune globulin routinely at about 28 weeks, and again after delivery if the newborn is Rh positive.
Show answer and reasoning
Answer: E. Give Rh immune globulin at this visit
- A. Repeat antibody testing has a role, but on its own it does not prevent sensitization. Routine prophylaxis at 28 weeks is the key step.
- B. Paternal testing is not required before routine antenatal prophylaxis, and an unknown or uncertain father is common. Prophylaxis should not be delayed.
- C. A Kleihauer-Betke or similar test measures fetomaternal hemorrhage after a sensitizing event or delivery. It is not needed for routine prophylaxis without an event.
- D. A postpartum dose is given if the baby is Rh positive, but waiting until delivery misses the routine antenatal dose that prevents most late-pregnancy sensitization.
- E. An Rh-negative, unsensitized patient should receive Rh immune globulin routinely at about 28 weeks, and again after delivery if the newborn is Rh positive.
Rh-negative, unsensitized pregnant patients receive Rh immune globulin routinely at about 28 weeks and after any sensitizing event.
Based on: SOGC guideline on prevention of Rh alloimmunization
Quick recall
Where candidates lose marks
- No pregnancy test
Ordering imaging, starting hormones or prescribing a teratogen before confirming pregnancy status is a common wrong answer.
- Fetus before mother
In an unstable pregnant patient, fetal monitoring or immediate delivery before maternal resuscitation is wrong.
- Digital exam in late bleeding
A digital vaginal exam before ultrasound excludes placenta previa can cause catastrophic hemorrhage.
- US screening ages
Starting cervical screening at a US age instead of the Canadian provincial age leads you to the wrong option.
- Ignoring the patient's goals
Treatment for PCOS, fibroids or endometriosis depends on whether she wants pregnancy now; options that ignore this are traps.
A study approach for obstetrics & gynecology
Read the MCC Examination Objectives for vaginal bleeding, pregnancy, amenorrhea, pelvic pain, contraception and infertility and note what each asks you to do.
Study the Obstetrics guide first and learn the trimester-based bleeding approach, hypertension rules, GDM screen and postpartum hemorrhage sequence.
Work through the Gynecology guide: abnormal bleeding, contraception eligibility, amenorrhea, screening, pelvic pain and menopause.
Finish with High-Risk Pregnancy and Adolescent Gynecology to link drug safety, pregnancy loss and confidentiality.
Do timed mixed blocks and keep a one-line error log of each decision point you miss.
In the final two weeks, mix OB/GYN with medicine and psychiatry blocks to practise spotting pregnancy inside other stems.
Sources and further reading
Check the current edition of each guideline before your exam.
- Medical Council of Canada: MCC Examination Objectives
- Society of Obstetricians and Gynaecologists of Canada: clinical practice guidelines
- Diabetes Canada Clinical Practice Guidelines: Diabetes and Pregnancy
- Canadian Immunization Guide: Immunization in pregnancy and breastfeeding
- Public Health Agency of Canada: Sexually transmitted and blood-borne infections guides
- Canadian Medical Protective Association: consent and confidentiality